[go: up one dir, main page]

NO20035737D0 - Vedvarende frigivelsessammensetning og prosess for å produsere det samme - Google Patents

Vedvarende frigivelsessammensetning og prosess for å produsere det samme

Info

Publication number
NO20035737D0
NO20035737D0 NO20035737A NO20035737A NO20035737D0 NO 20035737 D0 NO20035737 D0 NO 20035737D0 NO 20035737 A NO20035737 A NO 20035737A NO 20035737 A NO20035737 A NO 20035737A NO 20035737 D0 NO20035737 D0 NO 20035737D0
Authority
NO
Norway
Prior art keywords
produce
same
sustained release
release composition
composition
Prior art date
Application number
NO20035737A
Other languages
English (en)
Other versions
NO333531B1 (no
NO20035737L (no
Inventor
Kazumichi Yamamoto
Akiko Yamada
Yoshio Hata
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26617908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20035737(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20035737D0 publication Critical patent/NO20035737D0/no
Publication of NO20035737L publication Critical patent/NO20035737L/no
Publication of NO333531B1 publication Critical patent/NO333531B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20035737A 2001-06-29 2003-12-19 Vedvarende frigivelsessammensetning, farmasoytikum, fremgangsmate for fremstilling derav samt anvendelse NO333531B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001199462 2001-06-29
JP2001340980 2001-11-06
PCT/JP2002/006526 WO2003002091A2 (en) 2001-06-29 2002-06-28 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same

Publications (3)

Publication Number Publication Date
NO20035737D0 true NO20035737D0 (no) 2003-12-19
NO20035737L NO20035737L (no) 2004-02-20
NO333531B1 NO333531B1 (no) 2013-07-01

Family

ID=26617908

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035737A NO333531B1 (no) 2001-06-29 2003-12-19 Vedvarende frigivelsessammensetning, farmasoytikum, fremgangsmate for fremstilling derav samt anvendelse

Country Status (31)

Country Link
US (3) US20040241229A1 (no)
EP (2) EP1399133B2 (no)
JP (3) JP5491318B2 (no)
KR (3) KR20090096755A (no)
CN (1) CN1535141B (no)
AR (1) AR034640A1 (no)
AT (1) ATE429903T1 (no)
AU (1) AU2002311630B2 (no)
BR (1) BR0210572A (no)
CA (1) CA2451718C (no)
CO (1) CO5540368A2 (no)
CY (1) CY1109272T1 (no)
CZ (1) CZ306388B6 (no)
DE (1) DE60232147D1 (no)
DK (1) DK1399133T4 (no)
ES (1) ES2324156T5 (no)
HU (1) HU230152B1 (no)
IL (1) IL159060A0 (no)
MX (1) MXPA03011440A (no)
MY (1) MY139606A (no)
NO (1) NO333531B1 (no)
NZ (1) NZ529968A (no)
PE (1) PE20030069A1 (no)
PL (1) PL212531B1 (no)
PT (1) PT1399133E (no)
RU (2) RU2297240C2 (no)
SI (1) SI1399133T2 (no)
SK (1) SK287568B6 (no)
TW (1) TWI225416B (no)
WO (1) WO2003002091A2 (no)
ZA (1) ZA200309153B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2490351C (en) 2002-06-25 2011-11-01 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
DE60315472T2 (de) * 2002-09-24 2008-04-30 Asahi Kasei Chemicals Corp. Glycolsaüre copolymer und verfahren zu dessen herstellung
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
TW200613012A (en) * 2004-07-02 2006-05-01 Takeda Pharmaceuticals Co Sustained-release composition, process for producing the same and use of the same
DE602006000381T2 (de) * 2005-04-28 2008-12-18 Nipro Corp., Osaka Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer
DK1984009T3 (da) 2006-01-18 2013-01-28 Qps Llc Farmaceutiske sammensætninger med forbedret stabilitet
CN101563068B (zh) * 2006-12-18 2013-03-20 武田药品工业株式会社 缓释组合物和其制备方法
DK3660073T3 (da) 2007-02-15 2023-09-18 Tolmar International Ltd Poly(lactid-co-glycolid) med lav sprængning
KR101008462B1 (ko) * 2007-07-26 2011-01-14 조남열 치어류 이동용 어도 장치
KR100969641B1 (ko) * 2007-11-12 2010-07-14 민선영 저수지의 제방용 어도
KR100969642B1 (ko) * 2007-11-15 2010-07-12 민선영 하천의 보용 어도
TWI477266B (zh) * 2009-11-05 2015-03-21 Taiwan Biotech Co Ltd 連續製備微粒的方法、裝置及其收集單元
US8641900B2 (en) 2009-11-05 2014-02-04 Taiwan Biotech Co., Ltd Method and device for continuously preparing microspheres, and collection unit thereof
EP2697361A1 (en) * 2011-04-11 2014-02-19 Cellcura Asa Protein-free culture media products for manufacturing viral-based vaccines
US9517210B2 (en) 2012-07-12 2016-12-13 Takeda Pharmaceutical Company Limited Method for producing microcapsule powder
RU2572992C2 (ru) * 2012-08-28 2016-01-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Способ получения микрокапсул водорастворимых препаратов пестицидов
JP5959728B2 (ja) 2013-04-11 2016-08-02 三井化学株式会社 乳酸―グリコール酸共重合体の製造法またはその塩の製造法
RU2537173C1 (ru) * 2013-05-24 2014-12-27 Александр Александрович Кролевец Способ получения микрокапсул гетероциклических соединений триазинового ряда
RU2537248C1 (ru) * 2013-05-24 2014-12-27 Екатерина Евгеньевна Быковская Способ получения микрокапсул гетероциклических соединений триазинового ряда
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
EP3131532A1 (de) 2014-04-16 2017-02-22 Veyx-Pharma GmbH Veterinärpharmazeutische zusammensetzung und deren verwendung
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
CN104224731A (zh) * 2014-09-11 2014-12-24 北京天晟泰丰医药科技有限公司 一种不含致敏性辅料的九肽微球的制备方法
JP5938762B1 (ja) 2015-09-01 2016-06-22 日揮株式会社 マイクロカプセル製剤及びその製造方法
CN110856690B (zh) * 2018-08-22 2024-07-02 深圳善康医药科技股份有限公司 一种植入剂包膜及干燥装置
WO2021234731A1 (en) * 2020-05-18 2021-11-25 Dr Reddy's Institute Of Life Sciences Sustained release compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
JPH0678425B2 (ja) 1984-07-06 1994-10-05 和光純薬工業株式会社 重合体の新規製造法
CA1256638A (en) 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
JPH0720859B2 (ja) 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
EP0190833B1 (en) 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
EP0480918A1 (en) 1988-02-10 1992-04-22 Abbott Laboratories Reduced size lhrh analogs
US5110904A (en) 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
JP3200706B2 (ja) 1990-04-13 2001-08-20 武田薬品工業株式会社 生体内分解型高分子重合物
DE69129770T2 (de) * 1990-04-13 1998-11-19 Takeda Chemical Industries Ltd Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung
CA2079509C (en) * 1991-10-01 2002-05-14 Shigeyuki Takada Prolonged release microparticle preparation and production of the same
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
JP3761594B2 (ja) * 1993-07-05 2006-03-29 武田薬品工業株式会社 徐放性製剤の製造法
JPH08259460A (ja) 1995-01-23 1996-10-08 Takeda Chem Ind Ltd 徐放性製剤の製造法
CA2192782C (en) * 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
JPH11269094A (ja) 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
US6740634B1 (en) * 1998-01-16 2004-05-25 Takeda Chemical Industries, Ltd. Sustained release compositions, process for producing the same and utilization thereof
CN1134479C (zh) † 1998-12-15 2004-01-14 武田药品工业株式会社 制备聚合物的方法
JP3716146B2 (ja) * 1998-12-15 2005-11-16 武田薬品工業株式会社 ポリマーの製造方法
JP2002114667A (ja) 2000-10-11 2002-04-16 Ltt Institute Co Ltd 徐放性製剤用組成物、その製造法および徐放性マイクロカプセル製剤
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
CA2490351C (en) * 2002-06-25 2011-11-01 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition

Also Published As

Publication number Publication date
TWI225416B (en) 2004-12-21
HK1061802A1 (en) 2004-10-08
HUP0400382A3 (en) 2010-01-28
JP5931147B2 (ja) 2016-06-08
CA2451718C (en) 2011-03-15
NO333531B1 (no) 2013-07-01
US20040241229A1 (en) 2004-12-02
EP1399133A2 (en) 2004-03-24
AU2002311630B2 (en) 2007-07-19
PT1399133E (pt) 2009-06-05
MY139606A (en) 2009-10-30
DK1399133T3 (da) 2009-08-03
SK287568B6 (sk) 2011-02-04
US20120295848A1 (en) 2012-11-22
JP2012136530A (ja) 2012-07-19
RU2004102503A (ru) 2005-03-10
PL212531B1 (pl) 2012-10-31
CA2451718A1 (en) 2003-01-09
CY1109272T1 (el) 2014-07-02
DK1399133T4 (da) 2012-07-23
ES2324156T5 (es) 2012-07-23
BR0210572A (pt) 2004-08-03
EP1399133B2 (en) 2012-05-02
JP2010280703A (ja) 2010-12-16
IL159060A0 (en) 2004-05-12
JP5860300B2 (ja) 2016-02-16
WO2003002091A3 (en) 2003-07-24
KR20090108640A (ko) 2009-10-15
AR034640A1 (es) 2004-03-03
NO20035737L (no) 2004-02-20
KR100988178B1 (ko) 2010-10-18
EP1399133B1 (en) 2009-04-29
EP2108363A1 (en) 2009-10-14
CZ20033492A3 (cs) 2005-01-12
NZ529968A (en) 2005-08-26
PL367491A1 (en) 2005-02-21
WO2003002091A2 (en) 2003-01-09
DE60232147D1 (de) 2009-06-10
SI1399133T2 (sl) 2012-08-31
RU2297240C2 (ru) 2007-04-20
KR20090096755A (ko) 2009-09-14
ATE429903T1 (de) 2009-05-15
JP2015007120A (ja) 2015-01-15
KR20040018401A (ko) 2004-03-03
HU230152B1 (hu) 2015-09-28
MXPA03011440A (es) 2004-07-01
CN1535141A (zh) 2004-10-06
RU2006143104A (ru) 2008-06-20
PE20030069A1 (es) 2003-03-17
RU2434644C2 (ru) 2011-11-27
HUP0400382A2 (hu) 2004-12-28
US20080108778A1 (en) 2008-05-08
ES2324156T3 (es) 2009-07-31
CZ306388B6 (cs) 2017-01-04
CO5540368A2 (es) 2005-07-29
ZA200309153B (en) 2005-01-26
SI1399133T1 (sl) 2009-10-31
CN1535141B (zh) 2013-04-24
JP5491318B2 (ja) 2014-05-14
US8258252B2 (en) 2012-09-04
SK15612003A3 (sk) 2004-07-07

Similar Documents

Publication Publication Date Title
NO20035737D0 (no) Vedvarende frigivelsessammensetning og prosess for å produsere det samme
NO20035738D0 (no) Kontrollert frigivelsessammensetning og metode for å produsere det samme
IS6915A (is) Lyfjablanda
DE60134423D1 (de) Flammhemmende polycarbonat-polyester zusammensetzung
FR2849088B1 (fr) Cadenas
DE60207790D1 (de) Umreifungsmaschine
NO20030614D0 (no) Anti-IL-12-antistoffer, sammensetninger, fremgangsmåter og anvendelser
GB0108082D0 (en) Topical composition
BR0210619A (pt) composição
IS7081A (is) Lyfjablanda
DE60201785D1 (de) Umreifungsmaschine
DE60221403D1 (de) Doppelstrom - verdichter
NO20031417D0 (no) Fischer-Tropsch prosess
EP1447978A4 (en) VIDEO SYNTHESIZER
EE200400094A (et) Paratsetamooli parenteraalne kompositsioon
DE60222336D1 (de) Umreifungsvorrichtung
DK1256754T3 (da) Spændebånd
ITTO20020744A0 (it) Composizione
DE50201194D1 (de) Umreifungsvorrichtung
NO20034617L (no) Fremgangsmåter for å inhibere viral replikasjon
DE60236298D1 (de) Festbindstange
ITTO20020745A0 (it) Composizione
NO20015838D0 (no) Prosess
DE60200786D1 (de) Feste zusammensetzung
DE60030140D1 (de) Strammvorrichtung

Legal Events

Date Code Title Description
MK1K Patent expired